Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barney S Graham

Showing results (151-160 of 394) with videos related to

Pageof 40
Sort By:
The Journal of Experimental Medicine|May 31, 2007
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responsesMelissa L Precopio, Michael R Betts, Janie Parrino, et al.
American Journal of Respiratory and Critical Care Medicine|April 17, 2002
Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in miceR Stokes Peebles, Koichi Hashimoto, Jason D Morrow, et al.
Journal of Virology|September 16, 2004
Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illnessKoichi Hashimoto, Barney S Graham, Mark W Geraci, et al.
Journal of Virology|February 14, 2006
Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodiesSurender Khurana, James Needham, Bonnie Mathieson, et al.
Science Translational Medicine|June 22, 2022
Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccineEmily Phung, Lauren A Chang, Maryam Mukhamedova, et al.
Vaccine|March 30, 2007
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccineAndrew T Catanzaro, Mario Roederer, Richard A Koup, et al.
Plos One|May 19, 2010
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infectionEric S Rosenberg, Barney S Graham, Ellen S Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2011
HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectableStephen C De Rosa, Evan P Thomas, John Bui, et al.
Frontiers in Immunology|June 30, 2020
Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen DevelopmentRebecca J Loomis, Guillaume B E Stewart-Jones, Yaroslav Tsybovsky, et al.
Cell|May 7, 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid AntibodiesDaniel Wrapp, Dorien De Vlieger, Kizzmekia S Corbett, et al.
Pageof 40

Showing results (151-160 of 394) with videos related to

Sort By:
Pageof 40
The Journal of Experimental Medicine|May 31, 2007
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responsesMelissa L Precopio, Michael R Betts, Janie Parrino, et al.
American Journal of Respiratory and Critical Care Medicine|April 17, 2002
Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in miceR Stokes Peebles, Koichi Hashimoto, Jason D Morrow, et al.
Journal of Virology|September 16, 2004
Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illnessKoichi Hashimoto, Barney S Graham, Mark W Geraci, et al.
Journal of Virology|February 14, 2006
Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodiesSurender Khurana, James Needham, Bonnie Mathieson, et al.
Science Translational Medicine|June 22, 2022
Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccineEmily Phung, Lauren A Chang, Maryam Mukhamedova, et al.
Vaccine|March 30, 2007
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccineAndrew T Catanzaro, Mario Roederer, Richard A Koup, et al.
Plos One|May 19, 2010
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infectionEric S Rosenberg, Barney S Graham, Ellen S Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2011
HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectableStephen C De Rosa, Evan P Thomas, John Bui, et al.
Frontiers in Immunology|June 30, 2020
Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen DevelopmentRebecca J Loomis, Guillaume B E Stewart-Jones, Yaroslav Tsybovsky, et al.
Cell|May 7, 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid AntibodiesDaniel Wrapp, Dorien De Vlieger, Kizzmekia S Corbett, et al.
Pageof 40